Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Hi Team, IMV 3rd quarter 2020 results and clinical update is good ?and worth to gamble on this company ?
Thanks as always,
Tak
Thanks as always,
Tak
Q: Is there a potentially worthwhile option in the Canadian market for a company that's working on a vaccine, even indirectly?
-
Regeneron Pharmaceuticals Inc. (REGN $742.10)
- $742.10 P/E (TTM): 17.67X Cap: $77.47B
- View REGN Profile
- View Questions on REGN
-
Pfizer Inc. (PFE $26.81)
- $26.81 P/E (TTM): 19.83X Cap: $153.41B
- View PFE Profile
- View Questions on PFE
-
IMV Inc. (IMV $1.12)
-
Inovio Pharmaceuticals Inc. (INO $1.57)
- $1.57 Cap: $109M
- View INO Profile
- View Questions on INO
-
Novavax Inc. (NVAX $9.51)
- $9.51 P/E (TTM): 3.73X Cap: $1.56B
- View NVAX Profile
- View Questions on NVAX
-
Moderna Inc. (MRNA $51.02)
- $51.02 Cap: $20.37B
- View MRNA Profile
- View Questions on MRNA
-
BioNTech SE (BNTX $88.72)
- $88.72 Cap: $22.43B
- View BNTX Profile
- View Questions on BNTX
Q: Is there a Canadian company that you would recommend that possibly would benefit from a vaccine to overcome Covid 19, if not what U.S. or international company would you recommend? Thank You.
Insiders
Share Information
News and Media